Are you a Stanford student interested in enrolling in MS&E 472: The Entrepreneurial Thought Leaders Seminar? Check out our course FAQ!

Pharmaceutical Companies: Challenges in Developing New Therapeutic Products

Gordon Ringold, Affymax Research Institute

Ringold talks about how the pharmaceutical industry is built on failure and inefficiency and has a small success rate. This recognition led to Surromed. The low success rate is driving the consolidation of companies, which is giving rise to mega players. Now a blockbuster product has to be a multibillion product. This can only change with a change in the processes it uses. New biotech companies are starving for funding and cash, he notes.